China Artificial Hip & Knee Joints Market Size, Share & Trends Analysis Report By Site (Hip Joints, Knee Joints), By End Use (Hospitals & Surgery Centers, Orthopedic Clinics), And Segment Forecasts, 2024 - 2030

China Artificial Hip & Knee Joints Market Size, Share & Trends Analysis Report By Site (Hip Joints, Knee Joints), By End Use (Hospitals & Surgery Centers, Orthopedic Clinics), And Segment Forecasts, 2024 - 2030


China Artificial Hip & Knee Joints Market Growth & Trends

The China artificial hip & knee joints market size is expected to reach USD 1.01 billion by 2030, registering a CAGR of 7.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. This can be attributed to the increasing prevalence of age-related joint disorders, particularly osteoarthritis and osteoporosis. As the population ages, the demand for joint replacement surgeries has surged, coupled with health concerns associated with aging. According to The World Bank Group data, the percentage of people aged 65 years and above in China has increased from 9.32% in 2013 to 14.27% in 2023. This demographic shift increased the demand for effective surgical solutions, thereby contributing to the market growth.

Another critical driver is the implementation of centralized procurement policies, which have dramatically reduced the costs associated with artificial joints. For instance, the Volume-Based Procurement (VBP) initiative in China has significantly transformed the healthcare landscape since its inception, particularly for artificial joints, with around the 9th round for VBP released by November 2023. This program aimed to reduce the costs of medical consumables through centralized bidding and negotiation strategies. This cost reduction has encouraged more patients to opt for surgical solutions rather than considering alternative treatments, thereby positively impacting market growth. This shift enhances patient outcomes and enhances competition among manufacturers to innovate and improve product offerings.

Moreover, minimally invasive procedures, which aim to reduce recovery time and complications, have gained significant demand among surgeons and patients. As healthcare providers focus on improving patient outcomes, the shift towards less invasive procedures has led to a rise in the number of joint replacement surgeries performed. This trend enhances patient outcomes and encourages more individuals to consider surgical options for joint issues that were previously managed through other alternatives. This growing preference for minimally invasive approaches is expected to drive the market for artificial joints as hospitals and clinics invest in advanced surgical technologies.

The governments have prioritized healthcare reform, increasing investments in hospitals and medical facilities, particularly in rural areas. This expansion has improved access to orthopedic care, enabling more patients to receive timely treatment for joint-related conditions. As healthcare accessibility improves, more individuals are anticipated to switch to joint replacement surgeries, thereby driving demand for artificial hip and knee joints in the market.

China Artificial Hip & Knee Joints Market Report Highlights
  • Based on site, the knee joint segment held the largest revenue share in 2023 owing to the rising prevalence of knee disorders, increasing number of knee arthroplasties, and increasing affordability of patients.
  • The hip joint segment is expected to grow at the fastest CAGR over the forecast period, due to technological advancements in implant design and surgical techniques enhance patient outcomes and satisfaction, making THAs more convenient.
  • Based on end use, the hospitals & surgery centers segment dominated the market in 2023, owing to the advanced surgical techniques, personalized attention, and comprehensive services offered by these facilities, which significantly improve patient outcomes.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Country scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Site outlook
2.2.2. End use outlook
2.2.3. Country outlook
2.3. Competitive Insights
Chapter 3. China Artificial Hip & Knee Joints Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. China Artificial Hip & Knee Joints Market: Technology Trend Analysis
3.4. China Artificial Hip & Knee Joints: Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.2. PEST Analysis
3.5. Regulatory Framework
Chapter 4. China Artificial Hip & Knee Joints Market Segment Analysis, By Site, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Site Market Share Analysis, 2023 & 2030
4.3. Segment Dashboard
4.4. China Artificial Hip & Knee Joints Market, by Site, 2018 to 2030
4.5. Hip Joints
4.5.1. Hip Joints market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.1. Total Hip
4.5.1.1.1. Total Hip market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.2. Partial Femoral Head
4.5.1.2.1. Partial Femoral Head market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.3. Hip Resurfacing
4.5.1.3.1. Hip Resurfacing market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.1.4. Revision Hip
4.5.1.4.1. Revision Hip market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Knee Joints
4.6.1. By Knee Products
4.6.2. Fixed-bearing Implants
4.6.2.1. Fixed-bearing Implants market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.3. Mobile-bearing Implants
4.6.3.1. Mobile-bearing Implants market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.4. By Knee Procedure
4.6.5. Total knee replacement
4.6.5.1. Total knee replacement market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.6. Partial knee replacement
4.6.6.1. Partial knee replacement market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.7. Revision knee replacement
4.6.7.1. Revision knee replacement market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. China Artificial Hip & Knee Joints Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. End Use Market Share Analysis, 2023 & 2030
5.3. Segment Dashboard
5.4. China Artificial Hip & Knee Joints Market, by end use, 2018 to 2030
5.5. Hospitals & Surgery Centers
5.5.1. Hospitals & Surgery Centers market estimates and forecasts, 2018 to 2030 (USD million)
5.6. Orthopedic Clinics
5.6.1. Orthopedic Clinics market estimates and forecasts, 2018 to 2030 (USD million)
5.7. Others
5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company Categorization
6.3. Company Profiles
6.3.1. Zimmer Biomet
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Product benchmarking
6.3.1.4. Strategic initiatives
6.3.2. Stryker
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Product benchmarking
6.3.2.4. Strategic initiatives
6.3.3. Smith+Nephew
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Product benchmarking
6.3.3.4. Strategic initiatives
6.3.4. AK Medical
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Waston Medical Corporation
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Extremity Medical LLC
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. CONMED Corporation.
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Enovis Corporation
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Johnson & Johnson (DePuy Synthes)
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Aesculap, Inc. (B. Braun)
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings